Introduction: Changes in perinatal environment can lead to physiological, morphological, or metabolic alterations in adult life. It is well known that thyroid hormones (TH) are critical for the development, growth, and maturation of organs and systems. In addition, TH interact with the renin-angiotensin system (RAS), and both play a critical role in adult cardiovascular function. The objective of this study was to evaluate the effect of maternal hyperthyroidism on cardiac RAS components in pups during development. Materials and methods: From gestational day nine (GD9), pregnant Wistar rats received thyroxine (T4, 12 mg/l in tap water; Hyper group) or vehicle (control group). Dams and pups were killed on GD18 and GD20. Results: Serum concentrations of triiodothyronine (T3) and T4 were higher in the Hyper group than in the control group dams. Cardiac hypertrophy was observed in Hyper pups on GD20. Cardiac angiotensin-converting enzyme (ACE) activity was significantly lower in Hyper pups on both GD18 and GD20, but there was no difference in Ang I/Ang II levels. Ang II receptors expression was higher in the Hyper pup heart on GD18. Conclusions: Maternal hyperthyroidism is associated with alterations in fetal development and altered pattern of expression in RAS components, which in addition to cardiac hypertrophy observed on GD20 may represent an important predisposing factor to cardiovascular diseases in adult life.
Introduction
Thyroid hormones (TH) play an essential role in embryogenesis and fetal maturation. In addition, various studies have demonstrated that TH are critical for normal central nervous system development. [1] [2] [3] [4] Given that TH cross the placenta, the fetal endocrine response to adverse conditions reflects the joint activity of the maternal and fetal endocrine glands. 5 Although maternal hypothyroidism has been extensively investigated, 6 there have been few studies of the effects that maternal hyperthyroidism during pregnancy has on fetal growth. However, it is known that the prevalence of overt hyperthyroidism is 0.5% and that overt maternal hyperthyroidism is associated with heart failure, preeclampsia, preterm delivery, still birth, and neonatal mortality. 7 In adults, TH exert a wide variety of effects on the cardiovascular system, acting on cardiac contractility, cardiac output, blood pressure, and systemic vascular resistance. 8, 9 However, the role of TH during heart development remains unknown. Studies developed by our group and by other researchers have demonstrated a close relationship between the action of TH and that of the renin-angiotensin system (RAS) in regulating cardiac function in adults. [10] [11] [12] Pharmacological blockade of angiotensin-converting enzyme (ACE) or of angiotensin II receptor type 1 (AT 1 ) has been shown to prevent thyroid hormone-induced cardiac hypertrophy. 11 In addition, RAS plays an important role in heart development and fetal growth since all RAS components are expressed early in human development. 13 In addition, reports of severe fetal malformations in hypertensive women treated during pregnancy with ACE inhibitors have been described, which supports the role of angiotensin II (Ang II), the major RAS component, in organogenesis. 14 Although it has been demonstrated that there is an association between the RAS and TH in adults, little is known regarding the interaction between these two endocrine systems during the critical period of heart development. Therefore, the aim of the present study was to evaluate the repercussions of maternal hyperthyroidism for intrauterine development, as well as for the pattern of expression of cardiac RAS components.
Materials and methods

Animals
All surgical procedures and protocols were performed in accordance with the Ethical Principles in Animal Research set forth by the Brazilian College of Animal Experimentation and were approved by the Animal Research Ethics Committee of the University of São Paulo, Institute of Biomedical Sciences, Brazil. Male and female Wistar rats were obtained from the animal facilities of the Institute of Biomedical Sciences. Rats were given free access to standard rat chow and water and were housed in a temperaturecontrolled (24°C) environment on a 12/12-h light/dark cycle. At 12 weeks of age, female rats were allowed to mate with male rats. Day 0 of pregnancy was defined as the day on which spermatozoa were detected in a vaginal smear. All pregnant rats were separated and housed individually.
A total of 29 dams were used in this study. In one group of dams (n=16), designated the hyperthyroidism group (Hyper), maternal hyperthyroidism was induced by adding T4 to drinking water (12 mg/l of tap water) from gestational day nine (GD9), as described previously. 15 A control group (n=13) comprised dams receiving vehicle only. On GD18 and GD20, dams and pups were weighed and killed by decapitation. From the dams, trunk blood samples were collected (without anticoagulant). Hearts and tibias were extracted in order to determine the heart weight/tibia length ratio, a parameter of cardiac hypertrophy, which is commonly observed in hyperthyroidism. 16 In addition, a minimum of 30 pups per group were collected and used to analyze the weight of heart, kidney, lung and placenta on GD18 or GD20.
Maternal serum TH measurement
Immediately after collection, trunk blood samples were centrifuged (3000 rpm for 15 min at 4 °C) and stored at −20°C. The serum levels of total T4, free T4 and total T3 were determined by a commercial radioimmunoassay kit, with 125 I-labeling (Coat-A-Count kit; Siemens Healthcare Diagnostics, Los Angeles, CA, USA).
Immunoblotting analysis
To evaluate the expression of cardiac RAS components, total protein was obtained from hearts using an extraction buffer (3 M KCl; 1 M N-2-hydroxyethylpiperazine-N'-2ethanesulfonic acid; 1 M MgCl 2 ; 0.5 M ethylenediaminetetraacetic acid; 10% glycerol; 1 M dithiothreitol; 10% sodium dodecyl sulfate). The samples were loaded on a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel for electrophoresis using a Bio-Rad mini-gel apparatus and the fractionated protein on the gel was transferred onto a membrane, which was incubated with primary antibodies against AT 1 or AT 2 receptors (Alomone Labs, Jerusalem, Israel), as well as against Ang I/II and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After that, the membrane was probed with secondary antibodies against peroxidase-conjugated anti-mouse and anti-goat immunoglobulin G (Amersham Biosciences, Piscataway, NJ, USA). Signal detection was achieved with enhanced chemiluminescencedetection reagents (Amersham Biosciences) and exposure to X-ray film. The protein bands were quantified by densitometry. Quantitative analysis was performed by measuring the intensity of the bands normalized to the intensity of the GAPDH band.
Biochemical assay
Tissue samples were harvested, rinsed and homogenized in 0.4 M sodium borate buffer, pH 7.2. The ACE activity was determined by a method described previously. 17 In brief, supernatants from homogenized tissues were incubated with buffer containing 5 mM Hip-His-Leu (Sigma, St. Louis, MO, USA) in 0.4 M sodium borate buffer. The reaction was stopped by the addition of 0.34 M NaOH. The product, His-Leu, was measured fluorimetrically (excitation, 365 nm; emission, 495 nm). Subsequently, we added o-phthaldialdehyde (20 mg/ml) in methanol. After 10 min, the solution was acidified (3 N HCl) and centrifuged (3000 rpm for 10 min at room temperature (RT)). To correct for the intrinsic fluorescence of the tissue time, zero blanks were prepared. All samples were subjected to the assay in duplicate. The sensitivity of this assay is 0.02 nmol/mg tissue/min. The fluorescence intensity is linear, and the concentration of His-Leu generated is 0.02-15 nmol/mg/min in each tissue sample. Protein was measured by the Bradford method, 18 with bovine serum albumin as a standard.
Statistical analysis
Data are expressed as mean ± SD or as fold of induction in relation to the control group. Statistical analysis was performed with Student's t test, and values of p < 0.05 were considered statistically significant.
Results
Maternal hyperthyroidism
The serum levels of T3 and T4 presented significantly increased in the Hyper group when compared to the control group (5.5 and 12.0 fold higher, respectively), confirming the efficiency of the experimental model (Table 1 ). In addition, water and food intakes were evaluated in the experimental groups. While there was no difference in food intake, the water intake was significantly increased on GD20 in the Hyper group. Although no significant difference has been observed in the weight gain between both experimental groups on GD18 and GD20, there was a tendency to increase in this parameter in Hyper groups (Table 1) .
Heart weight/tibial length ratios (in g/mm) for Hyper group dams at both time points studied (GD18, n= 7 and GD20, n = 9) were higher when compared to the control group (GD18, n = 6 and GD20, n = 7), showing a significant cardiac hypertrophy (0.025 ± 0.002 vs 0.019 ± 0.001 on GD18 and 0.024 ± 0.001 vs 0.019 ± 0.002 on GD20; p < 0.05).
The placental wet weight was also evaluated, and a significant increase was observed in the Hyper group on GD18 when compared to the control group (0.46 ± 0.05* vs 0.41 ± 0.04 g). However, no difference was detected on GD20 (0.50 ± 0.08 vs 0.49 ± 0.05 g).
Regarding litter size (number of pups in utero), no difference was observed in both experimental groups (Hyper and control) on both gestational days (GD18 and GD20).
Effect of maternal hyperthyroidism on pup body weight
Mean body weight was significantly higher in the pups obtained from Hyper dams in both GD18 (12.7%) and GD20 (10.4%) groups, when compared with those obtained from control groups (Figure 1 ).
Effect of maternal hyperthyroidism on pup cardiac weight
The cardiac weight in the pups obtained from Hyper dams in both gestational periods (GD18 and GD20) exhibited a significant increase when compared with those of control group (Figure 2 ). When the cardiac weight was analyzed in relation to pup body weight, this significant increase was maintained only on GD20 (Figure 2) .
In parallel, we also observed the effect of maternal hyperthyroidism on kidney and lung weight. Pups from Hyper dams on GD20 presented a significant increase of kidney/body weight ratio (3.7 ± 0.4 vs 3.5 ± 0.5 mg/g) and a decreased lung/body weight ratio (9.2 ± 2.3 vs 10.9 ± 2.2 mg/g).
Effects of maternal hyperthyroidism on ACE activity and Ang I/Ang II expression levels in pup hearts
ACE activity given by nmol of His-Leu/min/mg of protein was significantly lower in the hearts of Hyper pups than in those of controls on both gestational days (64% on GD18 and 75% on GD20) ( Figure 3A ). We were unable to detect variations in Ang I/Ang II expression levels, which were evaluated by immunoblotting analysis (Figure 3B ). Table 1 . Serum thyroid hormone levels, water intake, food intake, litter size, and weight gain in the Hyper and control group rat dams on 18th and 20th gestational days (GD18 and GD20).
Variable
GD18 GD20
Control Hyper Control Hyper
Total T4 (nmol/l) 36.5 ± 7.94 (n = 3) >206 a (n = 3) 20.71 ± 3.86 (n = 5) >206 a (n = 5) Free T4 (nmol/l) 0.64 ± 0.20 (n = 3) 6.61 ± 1.63 a (n = 3) 0.34 ± 0.15 (n = 5) 6.99 ± 1.90 a (n = 5) Total T3 (nmol/l) 4.82 ± 1.79 (n = 3) 16.87 ± 1.9 a (n = 3) 5.74 ± 2.82 (n = 5) >20 a (n = 5) Water intake (ml/day) 53.0 ± 9.4 (n = 4) 56.2 ± 7.2 (n = 4) 45.8 ± 4.5 (n = 4) 63.8 ± 5.2 a (n = 4) Food intake (g/day) 25.4 ± 2.6 (n = 5) 26.65 ± 2.8 (n = 5) 22.63 ± 2.8 (n = 4) 25.7 ± 2.8 (n = 6) Litter size 9 ± 2 (n = 6) 12 ± 1 (n = 7) 9 ± 2 (n = 6) 11 ± 1 (n = 9) Weight gain(final weightinitial weight) 71.5 ± 11.9 (n = 6) 80.9 ± 14.7 (n = 7) 94.1 ± 16.7 (n = 6) 102.2 ± 13.2 (n = 9)
Values are expressed as mean ± SD. a p < 0.05. 
Effects of maternal hyperthyroidism on AT 1 and AT 2 angiotensin II receptor expression in pup hearts
Based on results showing a significant decrease on ACE activity of Hyper pups, the AT1 and AT2 angiotensin II receptors were also evaluated ( Figure 4 ). AT 1 and AT 2 receptor expression levels were upregulated in the hearts of Hyper pups on GD18, but this modulation was not detected on GD20.
Discussion
TH play a critical role in the development, growth, and metabolism of vertebrates. In fact, the influence of these hormones extends from the embryonic stage to the postnatal period. In adults, hyperthyroidism causes metabolic imbalance, which has been shown to be a major risk factor for the progression of certain cardiac diseases. 19 Epidemiological studies have suggested that a variety of adulthood diseases have their origins in intrauterine life, the development of such diseases being associated with a suboptimal perinatal environment. 20 In the present study, we evaluated the effect of maternal hyperthyroidism on fetal development, as well as the implications for the cardiac RAS of offspring. The effectiveness of our experimental protocol was confirmed by serum TH levels and by the heart weight/ tibia length ratio in the dams. Our data are in accordance with those of other studies using the same experimental protocol. 15, 21 Based on the fact that implantation and placental development occurs at approximately 50% of gestational age, we used GD9 to induce maternal hyperthyroidism, since before this period the placentation process might be impaired. It is important to consider that different fetal organs grow at different rates and that the timing of the insults determines the tissue specificity of the programmed effects. In this sense, in late gestation there is a period of fetal maturation during which many tissues undergo structural and functional changes in preparation for extrauterine life. 22 Thus, we believe that the evaluation of these periods of fetal maturation (GD18 and GD20) might signal possible functional changes observed in adult life. Considering that TH play an important role in the overall energy expenditure and in regulating the basal metabolic rate, 23, 24 the increased metabolic rate due to hyperthyroidism might be the major factor responsible for the increased water intake observed in the Hyper dams in GD20. In addition, we found that increased levels of maternal TH had no effect on the mean litter size. This finding is in agreement with those previously reported. 25 An interesting result obtained in this study corresponds to augmented body weight observed in the Hyper pups on GD18 and on GD20. Such results are probably attributable to the important role that TH play throughout the development, growth, and maturation of various organs and tissues. 26 In addition, some studies have demonstrated that TH are responsible for the activation of numerous processes related to the differentiation in multiple tissues. 27 Furthermore, it is important to take into account that both low and high birth weight have been frequently associated with elevated risk of developing cardiovascular disease as type 2 diabetes or hypertension later in life. 28, 29 Studies following the development of the pups into adult life are needed in order to clarify these points.
As previously mentioned, cardiovascular disorders are the most common pathologies observed during life. Data in the literature, including those obtained by our group, clearly demonstrate that TH have trophic effects on cardiac tissue in adults. 30, 31 In the present study, we found that on GD20 the heart/body weight ratio was higher in the Hyper pups than in the control group. This suggests that TH also induce significant cardiac hypertrophy in the fetal phase, which might have marked repercussions in adult life. Development, maturation, and pulmonary function are also influenced by TH, because there are TH receptors in multiple cell types of the lung and their expression in fetal lung tissue has been shown to be increased during gestation. 32 In addition, elevated TH levels can inhibit the expression of thyroid-transcription factor 1, which is necessary for normal lung epithelial differentiation and tissue organization. 33 Therefore, the lower lung/body weight ratios observed in Hyper pups on GD20 might indicate impaired lung development and maturation due to maternal hyperthyroidism.
Concerning renal development, maternal hyperthyroidism induced a renal hypertrophy in the pups on GD20, which is another common consequence of hyperthyroidism observed in adult life. 34 Some authors have suggested that renal hypertrophy occurring in hyperthyroidism may result from two distinct mechanisms: activation of the RAS, or hemodynamic changes. 10 In fact, some studies have observed a close interaction between these two endocrine systems (the RAS and the TH) in different cell types. Thus, the RAS acts as a key mediator of certain cardiovascular activities induced by TH, in vivo and in vitro. 11, [35] [36] [37] In addition, it is well known that the heart is the major target organ of TH, whose effects are partly mediated by modulation of certain RAS components. Therefore, our next question was to determine whether the close relationship between the RAS and TH would be observed in the offspring of mothers subjected to hyperthyroidism. The RAS has been reported to have growth-potentiating effects in several tissues, especially mediated by angiotensin II receptors, which act on renal and heart growth during development. 38, 39 First, we evaluated ACE activity in the heart of offspring, because ACE is the most important component of local Ang II production. 40 At both gestational days (GD18 and GD20) evaluated in our study, we found ACE activity levels significantly lower in cardiac tissue from Hyper pups than in the control group. In adult rats, we have previously demonstrated a similar reduction in cardiac ACE activity, with no modulation of serum ACE activity. 17 In rodents, Ang II, which is known to stimulate hypertrophy in cardiomyocytes and hyperplasia in non-myocytes, is produced primarily as a result of ACE activity. 41 Therefore, it is possible that decreased cardiac ACE levels may constitute a cardioprotection mechanism, preventing these hormones (TH and Ang II) from having an additive trophic effect on cardiac tissue. In addition, although we did not use the best experimental approach to assess the cardiac Ang II levels, since the antibody binds to both Ang I and Ang II, we were unable to detect variations on these peptides in cardiac tissue from Hyper pups at both gestational days. Nevertheless, the cardiac hypertrophy observed on GD20 might be attributable to the increased expression of type 1 (AT 1 ) and type 2 (AT 2 ) angiotensin II receptors observed in cardiac tissue on GD18. This finding is in agreement with data in the literature demonstrating the participation of these receptors in the development of TH-induced cardiac hypertrophy in adults. 37 Although previous studies have already evidenced a link between environmental insults leading to differential epigenetic alterations of AT 1 and AT 2 genes in the adrenal and kidney during fetal life, with a consequent alteration in their expression patterns in adult life, which can ultimately lead to the development of hypertension, 42 the present study shows, for the first time, the modulation of cardiac Ang II receptors during perinatal environment promoted by elevated levels of maternal TH. In addition, some authors recently demonstrated that the AT 2 /AT 1 ratio is an especially important measure of cardiac susceptibility to cardiovascular diseases, proposing that the pathophysiological function of AT 2 is context specific, i.e. dependent on the AT 2 /AT 1 ratio. 43, 44 Thus, based on our results we can suggest that decreased cardiac ACE activity observed in pups on GD18 and GD20 may be related to a relative diminution of Ang II production. Then, this decreased ACE activity followed by diminution of Ang II might promote an upregulation of AT 1 /AT 2 receptors, in order to compensate for this effect. With regard to the different pattern of expression of these receptors between GD18 and GD20, it may be related to the final period of gestational age, which is marked by activation of the RAS in order to prepare the fetuses for extrauterine life. In this sense, the AT 1 /AT 2 receptor density is extremely modified in this phase, decreasing dramatically after birth. 39 In summary, our data show the importance of TH regulation during gestation for the development, growth, maturation, and differentiation of tissues and organs, such as the heart, lungs, and kidneys. We also showed, for the first time, that TH promote upregulation of the AT 1 and AT 2 receptors, suggesting that the cardiac RAS also interacts with TH throughout fetal life. This interaction could be of great importance and might help explain numerous cardiovascular disorders occurring in adulthood. Given that hyperthyroidism results in clinically important stress on the fetus, it remains unclear whether the alterations observed during fetal life induce cardiovascular disorders in adulthood.
